Information  X 
Enter a valid email address

British Land Co PLC (BLND)

  Print      Mail a friend

Monday 16 December, 2019

British Land Co PLC

Director/PDMR Shareholding

RNS Number : 0258X
British Land Co PLC
16 December 2019
 

Director/PDMR Shareholding

The British Land Company PLC (the "Company") announces that on 16 December 2019, Darren Richards, a PDMR, sold 1,599 ordinary shares in the Company at a price of 630.45 pence per share. These shares had been acquired through the Company's Share Incentive Plan.

This notification is made in accordance with the requirements of the EU Market Abuse Regulation. 

 

 

Enquiries:

 

Company Secretariat

British Land   

020 7486 4466

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Darren Richards

2

Reason for the notification

a)

Position/status

PDMR - Executive Committee member

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

The British Land Company PLC

b)

LEI

RV5B68J2GV3QGMRPW209

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 25 pence each

 

ISIN: GB0001367019

b)

Nature of the transaction

Sale

c)

Price(s) and volume(s)

Nature of Transaction

Price(s)

Volume(s)

Sale

630.45p

1,599

 

d)

Aggregated information

-       Aggregated volume

-       Price

 

 

 

N/A

N/A

e)

Date of the transaction

16 December 2019

f)

Place of the transaction

London Stock Exchange (XLON)

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHZQLFFKLFLFBV

a d v e r t i s e m e n t